We are testing a new beta website for gov.scot go to new site

Review of Lymphoma Quality Performance Indicators Consultation

Description
ISBN9781788511506
Official Print Publication Date
Website Publication DateAugust 11, 2017

Listen

ISBN 978 1 78851 150 6 (web only publication)
PPDAS 281466

This document is also available in pdf format (572KB)
The Lymphoma Quality Performance Indicators (QPI) Engagement Document - Revised QPIs is available in pdf format (142KB)
The respondent information form is available in Word format (43KB)

Contents

1. National Cancer Quality Programme
1.1 Quality Assurance and Continuous Quality Improvement

2. Quality Performance Indicator Development Process

3. QPI Formal Review Process

4. Format of the Quality Performance Indicators

5. Supporting Documentation

6. Quality Performance Indicators for Lymphoma
QPI 1 - Radiological Staging
QPI 2 - Treatment Response
QPI 3 - Positron Emission Tomography (PET CT) Staging
QPI 4 - Cytogenetic Testing
QPI 5 - Lymphoma MDT
QPI 6 - Treatment for Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
QPI 10 - Primary Cutaneous Lymphoma
QPI 11 - Hepatitis and HIV Status
QPI 12 - Treatment Response in Hodgkin Lymphoma
QPI 13 - Maintenance Therapy for Follicular Lymphoma
QPI 14 - Clinical Trial Access

7. Survival

8. Areas for Future Consideration

9. Governance and Scrutiny
9.1 National
9.2 Regional - Regional Cancer Networks
9.3 Local - NHS Boards

10.How to participate in the engagement process
10.1 Submitting your comments
10.2 Engagement feedback

11. References

Appendices

Appendix 1: QPI Development Process

Appendix 2: Lymphoma QPI Development Group Membership (2012)

Appendix 3: Lymphoma QPI Formal Review Group Membership (2017)

Appendix 4: 3 Yearly National Governance Process & Improvement Framework for Cancer Care

Appendix 5: Regional Annual Governance Process and Improvement Framework for Cancer Care

Appendix 6: Glossary of Terms